Form D — Mirum Pharmaceuticals, Inc.
0001759425-26-000005 · filed 2026-01-29
Offering
- Industry
- Biotechnology
- Exemptions
- 06c
- Total offering
- $68,480,000
- Total sold
- $68,480,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Mirum Pharmaceuticals, Inc.
- CIK
- 1759425
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 989 EAST HILLSDALE BOULEVARD, SUITE 300
FOSTER CITY, CA 94404 - Phone
- 650-667-4085
Related persons
-
Christopher Peetz · Executive OfficerFoster City, CA
-
Eric Bjerkholt · Executive OfficerFoster City, CA
-
Peter Radovich · Executive OfficerFoster City, CA
-
Laura Brege · DirectorFoster City, CA
-
Timothy Walbert · DirectorFoster City, CA
-
William C. Fairey · DirectorFoster City, CA
-
Patrick Heron · DirectorFoster City, CA
-
Lon Cardon · DirectorFoster City, CA
-
Saira Ramasastry · DirectorFoster City, CA
-
Laurent Fischer · DirectorFoster City, CA
-
Michael Grey · DirectorFoster City, CA
View original on SEC EDGAR.